Axonics, Inc.
AXNXDelisted- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001603756
Axonics, Inc. was delisted in 2024; its insiders filed their last Form 4 on Nov 15, 2024; 233 institutions reported holding it in 13F filings for Q3 2024, worth $3.54B in total; Soros Fund Management was the only superinvestor holding it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 233
- Q3 2024, 0 vs. previous quarter
- 13F value
- $3.54B
- Reported value at the end of Q3 2024
- Superinvestors holding
- 1
- At the end of Q3 2024
Superinvestors holding AXNX, Q3 2024
1 superinvestor reports holding Axonics, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Soros Fund Management
George Soros
1.5%
Axonics, Inc.'s share of the portfolio
- Shares
- 1,050,001
- Value
- $73.1M
Latest insider trades
Open-market purchases and sales by Axonics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2024 (view filing) | Oct 2 | 1 day | Keese Kari LeighChief Financial Officer | SSale | −2.96K | $69.41 | −$205.5K | −6.8%40.4K after | 2 lots |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Noblett KarenChief Medical Officer | SSale | −11.3K | $67.74 | −$764.6K | −24.7%34.4K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Woock JohnEVP, Chief Mktg/Strtgy Officer | SSale | −15.9K | $67.74 | −$1.08M | −17.0%77.4K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Ford Alfred J JrChief Commercial Officer | SSale | −16.6K | $67.74 | −$1.13M | −27.7%43.5K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Keese Kari LeighChief Financial Officer | SSale | −3.49K | $67.74 | −$236.3K | −7.5%43.3K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Cohen Raymond WChief Executive Officer | SSale | −35.2K | $67.74 | −$2.38M | −15.7%188.8K after | |
| Jan 10, 2024 (view filing) | Jan 8 | 2 days | Noblett KarenChief Medical Officer | SSale | −16.0K | $69.00 | −$1.10M | −46.8%18.2K after | 10b5-1 |
| Dec 28, 2023 (view filing) | Dec 26-28 | 2 days | Noblett KarenChief Medical Officer | SSale | −8.00K | $63.25 | −$506.0K | −19.0%34.2K after | 2 lots10b5-1 |
| Oct 3, 2023 (view filing) | Sep 29 | 4 days | Dearen Danny L.President & CFO | SSale | −7.67K | $56.87 | −$436.5K | −24.4%23.8K after | |
| Oct 3, 2023 (view filing) | Feb 3, 2022 | 607 days | Dearen Danny L.President & CFO | SSale | −18.7K | $48.25 | −$901.5K | −32.3%39.2K after | Amended2 lots |
Top 10 13F holders, Q3 2024
The largest institutional positions in Axonics, Inc. at the end of Q3 2024; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 5,064,595 | $352.5M | 0.01% | +23,301+0.5% | Added |
| BlackRock, Inc. | 4,367,984 | $304.0M | 0.01% | +4,367,984 | New |
| HBK Investments L P | 2,470,852 | $172.0M | 3.16% | +341,222+16.0% | Added |
| Alpine Associates Management Inc. | 2,178,157 | $151.6M | 6.95% | +69,286+3.3% | Added |
| UBS Oconnor LLC | 2,148,826 | $149.6M | 3.71% | −48,454−2.2% | Reduced |
| FIL Ltd | 2,044,722 | $142.3M | 0.13% | +3,983+0.2% | Added |
| Davidson Kempner Capital Management LP | 1,547,519 | $107.8M | 2.34% | +113,845+7.9% | Added |
| Westchester Capital Management, LLC | 1,450,381 | $100.9M | 4.68% | +98,171+7.3% | Added |
| Omni Event Management Ltd | 1,360,463 | $94.7M | 11.78% | +139,916+11.5% | Added |
| Norges Bank | 1,321,656 | $92.0M | 0.01% | +50,000+3.9% | Added |